Effects of race on lipid-lowering management in hospitalized patients with coronary heart disease

被引:4
|
作者
Dressler, DD
Jacobson, TA
机构
[1] Emory Univ, Sch Med, Dept Med, Div Gen Med, Atlanta, GA 30303 USA
[2] Hosp Med Unit, Atlanta, GA USA
[3] Off Hlth Promot & Dis Prevent, Grady Hlth Syst, Atlanta, GA USA
来源
AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 93卷 / 09期
关键词
D O I
10.1016/j.amjcard.2004.01.052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this study was to determine the association between patient characteristics, specifically race, and the appropriate management of lipid-reducing therapy in patients with coronary heart disease (CHD) discharged from the hospital. Two hundred fifty-eight consecutive patients with diagnoses suggestive of CHD were identified in a large, inner-city university teaching hospital serving a predominantly indigent African American population. The outcome measure, suboptimal lipid management, evaluated the intensification of lipid-reducing therapy when indicated using the National Cholesterol Education Program guidelines for the low-density lipoprotein cholesterol goal. The overall rate of suboptimal lipid management was 48%. Black patients with CHD were significantly more likely to have suboptimal lipid management than nonblack patients by the time of hospital discharge (52.3% vs 16.7%, p = 0.021). The disparity in the clinical management of black patients with CHD may help explain the differential in health outcomes seen between black and white patients. (C) 2004 by Excerpta Medica, Inc.
引用
收藏
页码:1167 / 1170
页数:4
相关论文
共 50 条
  • [31] Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs
    Graham, DJ
    Staffa, JA
    Shatin, D
    Andrade, SE
    Schech, SD
    La Grenade, L
    Gurwitz, JH
    Chan, KA
    Goodman, MJ
    Platt, R
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21): : 2585 - 2590
  • [32] Effectiveness of hospital lipid-lowering protocol of intensive lipid-lowering therapy for patients with acute coronary syndrome
    Nakao, Sho
    Ishihara, Takayuki
    Tsujimura, Takuya
    Iida, Osamu
    Hata, Yosuke
    Toyoshima, Taku
    Higashino, Naoko
    Mano, Toshiaki
    JOURNAL OF CARDIOLOGY, 2022, 79 (03) : 391 - 399
  • [33] Cholesterol Levels and Lipid Lowering Treatment in Coronary Heart Disease Patients Hospitalized Because of Anginal Syndrome
    Raiyan, Ahmad
    Elis, Avisnay
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2024, 26 (10): : 577 - 582
  • [34] REVERSAL OF CORONARY HEART-DISEASE BY LIPID-LOWERING THERAPY - OBSERVATIONS AND PATHOLOGICAL MECHANISMS
    BROWN, BG
    MAHER, VMG
    CIRCULATION, 1994, 89 (06) : 2928 - 2933
  • [35] Protective lipid-lowering variants in healthy older individuals without coronary heart disease
    Lacaze, Paul
    Riaz, Moeen
    Sebra, Robert
    Hooper, Amanda J.
    Pang, Jing
    Tiller, Jane
    Polekhina, Galina
    Tonkin, Andrew
    Reid, Chris
    Zoungas, Sophia
    Murray, Anne M.
    Nicholls, Stephen
    Watts, Gerald
    Schadt, Eric
    McNeil, John J.
    OPEN HEART, 2021, 8 (02):
  • [36] Effects of lipid-lowering therapy on total and coronary mortality
    Holme, I
    CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (06) : 374 - 378
  • [37] Prevention of coronary heart diseases and lipid-lowering therapy in Japan
    Saito, Y
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2000, 2 (0D) : D49 - D50
  • [38] Effects of lipid-lowering therapy on coronary artery remodeling
    Schartl, M
    Bocksch, W
    Fateh-Moghadam, S
    CORONARY ARTERY DISEASE, 2004, 15 (01) : 45 - 51
  • [39] Lipid-lowering drugs in the treatment of ischemic heart disease
    Tashchuk, VT
    Polyanskaya, O
    Makoviichuk, I
    Penishkevich, I
    Shkvarkovskaya, A
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R644 - R644
  • [40] Lipid-lowering therapy in patients with coronary artery disease: Sex or age bias?
    Sgadari, A
    Incalzi, RA
    Onder, G
    Pedone, C
    Gambassi, G
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) : 2684 - +